RxSight's market cap is currently ―. The company's EPS TTM is $-1.421; its P/E ratio is -36.30; RxSight is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $-0.29. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 22.20M	$ 20.81M	$ 17.49M	$ 16.09M	$ 12.62M
Gross Profit	$ 13.73M	$ 12.02M	$ 10.37M	$ 7.42M	$ 5.36M
EBIT	$ -12.17M	$ -12.21M	$ -13.10M	$ -14.99M	$ -15.52M
EBITDA	-	$ -12.73M	$ -13.21M	$ -18.89M	$ -14.54M
Net Income Common Stockholders	$ -12.41M	$ -13.80M	$ -13.21M	$ -15.62M	$ -16.82M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 131.88M	$ 147.09M	$ 153.94M	$ 105.80M	$ 112.83M
Total Assets	$ 181.85M	$ 195.26M	$ 202.53M	$ 150.16M	$ 155.71M
Total Debt	$ 0.00	$ 19.59M	$ 40.31M	$ 40.17M	$ 45.33M
Net Debt	$ -131.88M	$ -127.50M	$ -113.63M	$ -65.63M	$ -67.51M
Total Liabilities	$ 20.37M	$ 38.07M	$ 57.52M	$ 60.26M	$ 59.75M
Stockholders Equity	$ 161.48M	$ 157.19M	$ 145.01M	$ 89.90M	$ 95.96M
Cash Flow	-
Free Cash Flow	-	$ -9.37M	$ -18.51M	$ -14.22M	$ -15.77M
Operating Cash Flow	$ -7.98M	$ -7.55M	$ -17.76M	$ -13.85M	$ -15.19M
Investing Cash Flow	$ 17.27M	$ 4.39M	$ -48.37M	$ 10.40M	$ 560.00K
Financing Cash Flow	$ -8.23M	$ 891.00K	$ 65.31M	$ 6.31M	$ -455.00K

Currency in USD

RxSight Earnings and Revenue History

Income Statement >

RxSight Debt to Assets

Balance Sheet >

RxSight Cash Flow

Cash Flow >

RxSight Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing